Immunotherapy in NSCLC faces challenges like high costs, limited access, and the need for optimized dosing and understanding of drug mechanisms. Precision medicine in breast cancer is evolving with ...
The future of healthcare is not just about treating patients when they come to the clinic. It is also about developing systems that help identify potential risks earlier and extend care beyond ...
To address gaps in care, the Association, devoted to changing the future of health for all, is using its Get With The Guidelines(R) data to support patient populations that may be underrepresented or ...
Q1 2026 earnings call: blarcamesine Alzheimer’s FDA/EMA timeline, ACCESS-AD partnership, and $131.7M cash runway—read now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results